ASX:MSBBiotechs
Is Mesoblast's New Clinical Leader Quietly Reframing Its Commercialization Story for Cell Therapies (ASX:MSB)?
Earlier this week, Mesoblast Limited created a new senior leadership role and appointed Teresa Montagut MD, PhD as Head of Clinical Development and Medical Affairs, reporting to Chief Medical Officer Dr. Eric Rose, to lead medical affairs, clinical collaborations and investigator-initiated trials across its cell therapy programs.
By bringing in a physician-scientist with extensive experience in early pipeline studies and investigator-sponsored research at major biopharmaceutical companies,...